Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00096941
Status:
COMPLETED
Last Update Posted:
2015-06-11
First Post:
2004-11-17
Brief Title:
A Study to Evaluate Subjects Treated With rhuMab 2C4 Pertuzumab in a Previous Genentech Phase II Cancer Study
Sponsor:
Genentech Inc
Organization:
Genentech Inc